Classifying Major Depressive Disorder Using Multimodal MRI Data: A Personalized Federated Algorithm

Zhipeng Fan1, Jingrui Xu1, Jianpo Su1

  • 1College of Intelligence Science and Technology, National University of Defense Technology, Changsha 410073, China.

Brain Sciences
|October 29, 2025
PubMed
Summary

Federated learning enables collaborative training of brain imaging models for major depressive disorder (MDD) diagnosis across multiple institutions without sharing sensitive MRI data. The pF-GMCO algorithm achieved 79.07% accuracy, offering a privacy-preserving diagnostic framework.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...